GABARAPL1 and neoplasm: Autophagy activation observed previously in tumor-bearing mice (Liu et al., 2021; Sin et al., 2021) was recapitulated in cancer patients including increase of LC3b and Gabarapl1 as well as active ULK-1, which were accompanied by reduced p62 as expected.